- AmeriCann ( OTCQB:ACAN ) achieved a significant increase in Y/Y quarterly revenue, increasing over 36% for the quarter ended June 2022 relative to the quarter ended June 2021, an increase of $213,902.
- Monthly revenue for June 2022 increased 30% from June 2021.
- The performance is attributable to greater revenue received from products produced and manufactured at Building 1, the company's initial building at its Massachusetts Cannabis Center development in Freetown, Massachusetts.
- The total Massachusetts market has sold $3.2B since the inception of the Commonwealth’s regulated cannabis program.
- “We’re pleased with achieving record revenue for the quarter and with the strong top-line growth rate. Our operating margins are very strong, and we look forward to reporting our full quarterly financial results in August of 2022.” stated President Tim Keogh.
For further details see:
AmeriCann sets a record of monthly and quarterly revenue